Novadip
novadip.com
Actively hiring
Regenerative Medicine
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$11.2M
1 round on record
Latest round
$11.2M
Venture round · Oct 2026 · this month
Backers
1
Fund+
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2026 | $11.2M | U.S lead | Pulse 2.0 |
Backed byfrom the funds' portfolios and accelerator catalogs
Fund+ Investors in similar startupsfunds that back the companies most like this one
backs Jointechlabs, DataBiologics
backs Allevi3D
backs Allevi3D
backs X-Therma
backs Qkine
backs Allevi3D
Similar startupsby what they do, their industry and backers
Discover Regenerative Medicine with D&P Bioinnovations. Transformative solutions for healing damaged tissues. Call us.
Jointechlabs enables healthcare practitioners to provide safe, cost-effective, non-surgical point-of-care regenerative medicine therapies.
Learn how DataBiologics empowers clinicians with real-world evidence to advance regenerative medicine. Meet the team behind the leading…
CoreBone offers tissue regeneration solutions for Bone and Cartilage from cultivated corals.
Healshape is a regenerative medicine company that develops a 100% natural, personalized and resorbable bioprosthesis for breast…
X-Therma pioneers a breakthrough biopreservation platform, transforming “living” medicines into on demand treatments. We empower patients…
Overview
Novadip is committed to patients and addresses some of today’s biggest challenges in bone and tissue regenerative medicine.
News
Novadip Raises €10.4 Million ($11.98 Million) To Complete NVD003 Phase 3 Trial
Novadip Biosciences has raised €10.4 million ($11.98 million) in convertible financing to advance its lead regenerative medicine program NVD003 through pivotal Phase 3 development and prepare for a U.S. regulatory submission. The financing was led by U.S.
Read more
Report
Novadip receives RMAT designation for NVD003, its regenerative treatment for congenital pseudarthosis of the tibia
Novadip receives RMAT designation for NVD003, its regenerative treatment for congenital pseudarthosis of the tibia. Novadip is developing NVD003, an autologous therapy derived from adipose stem cells, as a potential single treatment to save limbs and rest
Read more
Report
Novadip's bone graft material unifies fractures in 100% of patients
The Belgian company's NVDX3 bone graft saw all ten patients enrolled achieving wrist fracture unification.
Read more
Report
Novadip Biosciences SA announces significant clinical milestones for both of its clinical-stage programs
/PRNewswire/ -- Novadip Biosciences SA ("Novadip" or "the Company"), a clinical-stage biopharmaceutical company developing a new class of regenerative tissue...
Read more
Report
Novadip Biosciences SA Announces First Pediatric Patient with Congenital Pseudoarthrosis of the Tibia Undergoes Implantation with NVD-003, an Autologous Tissue Regeneration ...
Read more
Report
Novadip Biosciences Raises Additional EUR 40 Million Bringing Total Company Funding to EUR 88 Million
Read more
Report
PharmiWeb.com - Thank you
After twenty-five years, PharmiWeb.com is closing. A note of thanks to the pharmaceutical industry community that built it.
Read more
Report
Novadip Biosciences to Present at the LifeSci Partners Summer Symposium
Novadip Biosciences to Present at the LifeSci Partners Summer Symposium Mont-Saint Guibert, Belgium, 29 July, 2020: Novadip Biosciences ("Novadip" or "the Company"), a clinical-stage biopharmaceutical
Read more
Report
Novadip Biosciences to unveil its 3M3 Platform at BIO Digital 2020
Novadip Biosciences to unveil its 3M3 Platform at BIO Digital 2020 -Unique 3M3 tissue regeneration technology platform generates multiple product candidates:.
Read more
Report
Show more news
Financials
Total raised
$11.2M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $11.2M | Details |